Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
Stéphanie Forté(University Health Network), Kevin H.M. Kuo(University Health Network), Anne-Laure Pham Hung D'Alexandry D'Orengiani(Inserm), John Aneke(University Health Network), Henri Guillet(Université Paris-Est Créteil), Dalton Budhram(University Health Network), Pablo Bartolucci(UNESCO), Olivia Pestrin(University Health Network), Nafanta Fadiga(University Health Network), Jameel Abdulrehman(University Health Network), Gonzalo De Luna(Université Paris-Est Créteil), Richard Ward(University of Tennessee Health Science Center), Anoosha Habibi(Université Paris-Est Créteil)
Cited by 14
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Online haemodiafiltration: definition, dose quantification and safety revisited
|Nephrology Dialysis Transplantation|2013|256
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162